Myda Advisors LLC Sesen Bio, Inc. Transaction History

Myda Advisors LLC

  • $407 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019
SELL
$0.96 - $2.04 $48,000 - $102,000
-50,000 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$1.54 - $2.38 $77,000 - $119,000
-50,000 Reduced 50.0%
50,000 $108,000
Q2 2018

Aug 13, 2018
BUY
$1.04 - $3.29 $104,000 - $329,000
100,000 New
100,000 $195,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Sesen Bio, Inc.

SESN Quotes by TradingView
  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Myda Advisors LLC Portfolio

Follow Myda Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Myda Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email